Lymphoma Treatment Market to be Led by Bayer AG and Novartis AG, sates Fortune Business Insights™
The global “lymphoma treatment market” size is predicted to reach USD 13.11 billion by 2026, exhibiting a CAGR of 8.3% during the forecast period. The increasing R&D investments for strong pipeline candidates by prominent players will contribute positively to the lymphoma treatment market revenue in the forthcoming years. For instance, Agios Pharmaceuticals, Inc. announced its...
0 Comments 0 Shares